Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 14,090

Document Document Title
WO/2019/007944A1
The present invention relates to a methylglycine-N,N-diacetic acid trisodium salt in the form of a crystal, comprising a crystalline modification referred to as crystal type III characterized by the below reflections when analyzed with X...  
WO/2019/007943A1
The present invention relates to a process for the preparation of a solid composition of an amino acid diacetic acid compound wherein the amino acid diacetic acid compound is methyl glycine-N,N-diacetic acid or a salt thereof, or glutami...  
WO/2019/002022A1
The present invention is directed towards a process for manufacturing a complexing agent, said process comprising the steps of (a) Providing a nitrile according to general formula (I a) or (I b) (formula I a, I b) With M being selected f...  
WO/2019/002685A1
The present invention relates to a process for in situ the preparation of mixtures of chelating agents by catalyzed reactions of diethanolamine derivatives with maleic acid and then with 2-halocarboxylic acid, to mixtures of chelating ag...  
WO/2019/002684A1
The present invention relates to a process for the in situ preparation of mixtures of chelating agents by catalyzed reactions of diethanolamine with maleic acid and then with 2-halocarboxylic acid, mixtures obtainable using said process ...  
WO/2018/226841A1
Zwitterionic monomers, camitine-derived zwitterionic polymers, carnitine ester cationic monomers, carnitine ester cationic polymers, conjugate compositions including a carnitine-derived zwitterionic polymer, and related compositions' and...  
WO/2018/223836A1
The present invention relates to a novel crystal form of a compound (I), a method for preparing same, and an application. Crystal form CS3, crystal form CS2, crystal form CS5, and crystal form CS8 of the compound (I) provided by the pres...  
WO/2018/226340A1
A method for preparing diphenol compounds includes adding a hydroxyphenyl carboxylic acid, a tyrosine ethyl ester, hydroxybenzotriazole hydrate and a solvent and stirring to produce a first solution, EDCI HCI is added to the first soluti...  
WO/2018/225871A1
The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, R1 represents a hydrogen atom or a hydroxymethyl group; n1 represents 1 or 2; A1 and A2 may be the same ...  
WO/2018/212162A1
The purpose of the present invention is to provide a method for easily producing a diaminobenzene compound and a benzimidazole compound at low cost. The present invention provides a method for producing a diaminobenzene compound or N-pro...  
WO/2018/206540A1
Materials of the invention are suitable for use in coating compositions, inks, paints, varnishes, adhesives, for the making of gel coats, composites, molding compositions or 3D articles. Materials of the invention are in particular suita...  
WO/2018/207693A1
A 1–amino cyclopropane carboxylic acid nonhydrate can be produced as a result of: using a tertiary amine to treat a 1–amino cyclopropane carboxylic acid hydrochloride in the presence of a C3–C4 alcohol and water; maintaining the re...  
WO/2018/207694A1
A 1–amino cyclopropane carboxylic acid nonhydrate can be produced as a result of: using a tertiary amine to treat a 1–amino cyclopropane carboxylic acid hydrochloride in the presence of a C3–C4 alcohol and water; maintaining the re...  
WO/2018/208754A1
This invention relates to compositions and methods for treating or ameliorating symptoms of a neuropsychiatric disease in a subject in need thereof comprising: (a) a therapeutically effective amount of propofol; and (b) a therapeutically...  
WO/2018/208677A1
Embodiments of the present disclosure are related to improved processes for making L-ornithine phenylacetate without using any silver salts or forming any L-ornithine intermediate salts, such as a benzoate salt. The present processes may...  
WO/2018/204434A1
The present disclosure is related to the field of agrochemicals, including compound I and its use to control fungal diseases in agriculturally useful row crops.  
WO/2018/204438A1
The present disclosure is related to the field of agrochemicals, including compound I and its use to control fungal diseases on turfgrasses.  
WO/2018/204435A1
A fungicidal composition containing a fungicidally effective amount of the compound of Formula I, (S)-l,l-bis(4-fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-L- alaninate, and at least one fungicide selected from the group con...  
WO/2018/204437A1
A fungicidal composition containing a fungicidally effective amount of the compound of Formula I, (S)-1,1-bis(4-fluorophenyl)propan-2-y1 (3-acetoxy-4-methoxypicolinoy1)-L-alaninate, and at least one fungicide selected from the group cons...  
WO/2018/204869A1
The present invention relates to conjugates including a chelating moiety of a metal complex thereof and a therapeutic or targeting moiety, methods for their production, and uses thereof.  
WO/2018/204431A1
The present disclosure relates to the use of the compound of Formula I, (S)-1,1-bis(4- fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-L-alaninate, as a seed treatment to prevent or control plant diseases.  
WO/2018/204436A1
A fungicidal composition containing a fungicidally effective amount of the compound of Formula I, (S) -1,1-bis (4-fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-L-alaninate, and at least one fungicide selected from the group co...  
WO/2018/204433A1
The present disclosure is related to the field of agrochemicals, including compound I and its use to control fungal diseases in agriculturally useful orchard, vineyard and plantation crops.  
WO/2018/204432A1
The present disclosure is related to the field of agrochemicals, including compound (I) and its use to control fungal diseases in agriculturally useful vegetable crops.  
WO/2018/197475A1
The present invention provides processes for preparing a compound of formula (I) and pharmaceutically acceptable salts thereof, comprising deprotecting a compound of formula (II), wherein each R3 independently represents a tertiary alkyl...  
WO/2018/177383A1
The present application relates to extracting, from a traditional Chinese medicine, a plurality of compounds capable of prompting nucleic acid delivery or synthetic compounds, and promoting nucleic acid such as sRNA to absorb and enter a...  
WO/2018/176150A1
Novel methods for isolating fish roe/egg extracts, notably a coagulum and a sediment extract, enriched in phospholipids and omega-3 fatty acids are described. Novel compositions comprising omega-3 polyunsaturated fatty acids and micronut...  
WO/2018/174826A1
This invention relates to a method for producing an alkenyl 1 -aminocyclopropane-1 -carboxylic acid of Formula I wherein R1 is a protecting group, n is an integer between 1 and 10, and A and B are chiral centres such that when A is S, B ...  
WO/2018/170322A1
Provided herein are novel solid forms of each of four compounds: (1) heptadecan-9-yl 8-((2-hydroxyethyl)amino)octanoate ("Compound 1"), (2) heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoat e ("Compound 2"),(3)...  
WO/2018/170306A1
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions fu...  
WO/2018/165120A1
Methods of treating obesity symptoms, metabolic disorders or lipodystropy by administering carboxyalkylethers, in particular 6,6'-oxybis-(2,2'-dimethylhexanoic acid) or an ester, hydrate or salt thereof.  
WO/2018/164662A1
A resveratrol ester has the following structure: (I). R1, R2 and R3 are H or (II). Each R4 is independently a carbon chain of 2 to 4 carbon atoms comprising a terminal carboxylic acid moiety, a carbon chain of 1 to 5 carbon atoms compris...  
WO/2018/162986A3
Fluorescence quenching nitrodiarylethene analogs are useful in oligonucleotide conjugates and probes. These analogs, whose absorption spectra are substantially blue-shifted relatively to emission spectra of common fluorophores (such as f...  
WO/2018/157842A1
The present invention provides a use of 2-(substituted phenylamino)benzoic acid FTO inhibitor in treating leukemia.  
WO/2018/157843A1
The preparation method provides 2-(substituted benzene matrix) aromatic formate FTO inhibitor, a preparation method therefor, and applications thereof. Specifically, disclosed in the present invention are a 2-(substituted benzene matrix)...  
WO/2018/153876A1
Process for making solid methylglycine diacetate (MGDA) alkali metal salt (a), said process comprising the steps of (A) providing a 35 to 60% by weight aqueous solution of said MGDA salt having a temperature in the range of from 50 to 90...  
WO/2018/150906A1
This liquid crystal display device 10 is provided with: a pair of substrates which have conductive films 14, 15, respectively; a liquid crystal layer 12 which is arranged between the pair of substrates and contains liquid crystals; and a...  
WO/2018/145553A1
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I), compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatricdisorder (e....  
WO/2018/148380A1
Methods of treating a seizure disorder with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carbox ylic acid, or (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxyl ic acid (KT-II-115), or a pharmaceutically acceptable sal...  
WO/2018/139311A1
[Problem] To provide a novel diamine compound with which it is possible to synthesize a polyimide compound having high solubility in organic solvents and high melt moldability. [Solution] This diamine compound is characterized by being r...  
WO/2018/132066A1
Disclosed are compounds having the following formula: (I) wherein R is an alkane chain having between 8 and 20 carbon atoms, and A is one or more anions having a total charge of -2; or R is a quaternary amine having the following formula...  
WO/2018/116203A1
The invention relates to a new enantioselective process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid, ...  
WO/2018/115434A1
The invention relates to a method for the production of acetylsalicylic acid lysinate, optionally lysine acetylsalicylate · glycine, comprising the following steps: a) providing a solution of acetylsalicylic acid in ethanol; b) providin...  
WO/2018/118838A1
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the en...  
WO/2018/107158A1
This present disclosure is directed to compounds of formula (I): where r, q, R1a, R1b, R1c, R1d, R1e, R2, R3, R4a, R5a, R5b, R6a, R6b, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceu...  
WO/2018/101329A1
The purpose of the present invention is to develop a therapeutic agent for inflammatory diseases such as inflammatory bowel disease and NASH, said therapeutic agent having few adverse effects and high efficacy. The present invention prov...  
WO/2018/096504A1
Compounds of Formula (I), including stereoisomers and salts thereof, and compositions, methods of treatment and prevention, and methods of preparing, the same: Formula (I) wherein X is O or a direct bond; wherein when X is O, R1 and R2 a...  
WO/2018/097431A1
The present invention provides a composition for protecting the skin from heavy metals and formaldehyde, comprising at least one selected from the group consisting of trientine or trientine derivative of Formula (1), cyclen or cyclen der...  
WO/2018/090963A1
The invention provides a method for preparing a lisinopril intermediate, comprising: treating (R)-hydroxy-4-phenylbutyrate with sulfonyl chloride in an organic solvent in the presence of a base to obtain a solution of sulfonate; reacting...  
WO/2018/090670A1
The present invention relates to a method for preparing a droxidopa intermediate (2S,3R)-3-(3,4-dibenzyloxyphenyl)-2-dibenzylamino-3-hydroxyp ropionate, comprising carrying out asymmetric hydrogenation to 3-(3,4-dibenzyloxyphenyl)-2-dibe...  

Matches 1 - 50 out of 14,090